ATE291424T1 - Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung - Google Patents

Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung

Info

Publication number
ATE291424T1
ATE291424T1 AT01988587T AT01988587T ATE291424T1 AT E291424 T1 ATE291424 T1 AT E291424T1 AT 01988587 T AT01988587 T AT 01988587T AT 01988587 T AT01988587 T AT 01988587T AT E291424 T1 ATE291424 T1 AT E291424T1
Authority
AT
Austria
Prior art keywords
catechin
quercetin
pharmaceutical
dietary use
dietary
Prior art date
Application number
AT01988587T
Other languages
English (en)
Inventor
Domenico Trimboli
Valter Gatti
Gian Carlo Naccari
Original Assignee
Giuliani Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani Spa filed Critical Giuliani Spa
Application granted granted Critical
Publication of ATE291424T1 publication Critical patent/ATE291424T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
AT01988587T 2000-10-25 2001-10-11 Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung ATE291424T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI002312A IT1320080B1 (it) 2000-10-25 2000-10-25 Composizione per uso farmaceutico o dietetico.
PCT/EP2001/011779 WO2002034262A1 (en) 2000-10-25 2001-10-11 Combination of catechin and quercetin for pharmaceutical or dietary use

Publications (1)

Publication Number Publication Date
ATE291424T1 true ATE291424T1 (de) 2005-04-15

Family

ID=11446037

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01988587T ATE291424T1 (de) 2000-10-25 2001-10-11 Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung

Country Status (12)

Country Link
US (1) US7956040B2 (de)
EP (1) EP1328268B1 (de)
JP (1) JP2004512304A (de)
AT (1) ATE291424T1 (de)
AU (2) AU2061702A (de)
CA (1) CA2425933C (de)
DE (1) DE60109632T2 (de)
ES (1) ES2238495T3 (de)
IT (1) IT1320080B1 (de)
NZ (1) NZ525339A (de)
PT (1) PT1328268E (de)
WO (1) WO2002034262A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100469776C (zh) 2002-05-17 2009-03-18 奥特拉控股公司 白内障和其它眼病发展的改善
EP2260845A3 (de) 2002-06-21 2012-08-22 L'Oréal Verwendung von Polyphenolen zur Behandlung der Alopezie
AU2007229399B2 (en) * 2002-06-21 2010-12-23 L'oreal Use of taurine or derivatives thereof for the treatment of alopecia
US7825134B2 (en) 2003-05-19 2010-11-02 Othera Holding, Inc. Amelioration of cataracts, macular degeneration and other ophthalmic diseases
EP1689354A4 (de) * 2003-11-20 2010-07-14 Othera Holding Inc Linderung von katarakten, makuladegeneration und anderen augenerkrankungen
EP1706107A1 (de) * 2004-01-07 2006-10-04 Unilever Plc Synergistische neuroprotektive kombinationen von flavanolen, hydroxystilbenen, flavanonen, flavonen, flavonolen, proanthocyanidinen und anthocyanidinen
DE102004041270A1 (de) * 2004-08-26 2006-03-02 Merz Pharma Gmbh & Co. Kgaa Ein Kapillar- Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung
JP2006083105A (ja) * 2004-09-16 2006-03-30 Ito En Ltd 血液流動性改善剤および飲食物
JP2008527002A (ja) * 2005-01-13 2008-07-24 サートリス ファーマシューティカルズ， インコーポレイテッド 神経変性障害および血液凝固障害を予防および処置するための新規組成物
US20060276416A1 (en) * 2005-01-20 2006-12-07 Sirtris Pharmaceuticals, Inc. Methods and compositions for treating flushing and drug induced weight gain
CA2634127C (en) * 2005-12-23 2016-06-07 Mars, Incorporated Skin protection and improvement
GB0819960D0 (en) * 2008-10-31 2008-12-10 Provexis Natural Products Ltd Therapeutic composition
IT1393841B1 (it) 2009-04-30 2012-05-11 Giuliani Spa Composizione farmaceutica o dermatologica o nutrizionale o cosmetica per combattere l'azione di immunosoppressione provocata sulla pelle da agenti aggressivi
IT1401289B1 (it) 2010-04-22 2013-07-18 Giuliani Spa Composti dotati di attivita' antiossidante nei confronti dei radicali liberi, e composizioni farmaceutiche e cosmetiche che li contengono
US20120183587A1 (en) * 2011-01-18 2012-07-19 Mitsunori Ono Flavonol compositions
ES2391211B1 (es) * 2011-05-04 2013-10-02 Select Botanical, S.L. Combinacion sinergica de polifenoles
FR2981272A1 (fr) * 2011-10-14 2013-04-19 Inneov Lab Utilisation d'une composition orale comprenant un melange d'au moins un polyphenol, de zinc, et de vitamine c.
JP5769611B2 (ja) * 2011-12-08 2015-08-26 株式会社ピカソ美化学研究所 育毛剤組成物
JP6310934B2 (ja) * 2012-11-29 2018-04-11 ネステク ソシエテ アノニム ポリフェノールによるフラバン−３−オールのバイオアベイラビリティの増大
ITMI20130397A1 (it) * 2013-03-15 2014-09-16 Giuliani Spa Composizione a base di flavonidi per uso farmaceutico, nutrizionale o cosmetico con potenziata azione antiossidante
EP4205750B1 (de) 2016-01-12 2025-04-09 Eaderm Co., Ltd. Nadph-oxidase-inhibitor zur unterdrückung oder verbesserung des haarverlusts oder zur behandlung von alopezie
WO2022255810A1 (ko) * 2021-06-04 2022-12-08 주식회사 엘지생활건강 항노화 화장료 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5244375B2 (de) * 1974-04-19 1977-11-08
JP3480953B2 (ja) * 1992-08-17 2003-12-22 株式会社コーセー 皮膚外用剤
JP3480956B2 (ja) * 1992-10-16 2003-12-22 株式会社コーセー 皮膚外用剤
US6569446B1 (en) * 1996-09-20 2003-05-27 The Howard Foundation Solubilization of flavonols
US6013632A (en) * 1997-01-13 2000-01-11 Emory University Compounds and their combinations for the treatment of influenza infection
US6054128A (en) * 1997-09-29 2000-04-25 Wakat; Diane Dietary supplements for the cardiovascular system
IT1296920B1 (it) * 1997-12-04 1999-08-03 Indena Spa Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-aterosclerotici
US6030621A (en) * 1998-03-19 2000-02-29 De Long; Xie Ginkgo biloba composition, method to prepare the same and uses thereof
AU6918700A (en) * 1999-08-20 2001-03-19 Howard Murad Pharmaceutical compositions and methods for reducing the appearance of cellulite

Also Published As

Publication number Publication date
AU2061702A (en) 2002-05-06
NZ525339A (en) 2004-10-29
AU2002220617B2 (en) 2005-04-28
CA2425933C (en) 2011-05-03
US20040014686A1 (en) 2004-01-22
ITMI20002312A1 (it) 2002-04-25
WO2002034262A1 (en) 2002-05-02
DE60109632T2 (de) 2006-02-09
DE60109632D1 (de) 2005-04-28
CA2425933A1 (en) 2002-05-02
EP1328268B1 (de) 2005-03-23
US7956040B2 (en) 2011-06-07
PT1328268E (pt) 2005-08-31
JP2004512304A (ja) 2004-04-22
IT1320080B1 (it) 2003-11-18
EP1328268A1 (de) 2003-07-23
ES2238495T3 (es) 2005-09-01

Similar Documents

Publication Publication Date Title
DE60109632D1 (de) Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung
TR200003735T2 (tr) Osteoporoz ve menopoz sendromuna bağlı rahatsızlıkların önlenmesi ve tedavileri
DE50306232D1 (de) Ampholytisches copolymer und dessen verwendung
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
BR9911724A (pt) Ciclosporina que tem um perfil de atividade melhorado
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
DE50004334D1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
ATE500747T1 (de) Zusammensetzung zur erhöhung der leistungsfähigkeit des körpers
MXPA03010158A (es) Sulfonamidas.
ATE554114T1 (de) Copolymer mit zwitterionischen einheiten und anderen einheiten, das copolymer umfassende zusammensetzung und verwendung
BRPI0508117A (pt) composições de bebida ácida
ATE537828T1 (de) Psychotropes mittel und nahrungsmittel zur förderung der gesundheit enthaltend neferin
ATE554753T1 (de) 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia
DK1307445T3 (da) Benzofuranderivater og deres anvendelse som antibakterielle midler
WO2004039326A3 (en) Propofol with cysteine
BR0307696A (pt) Composição desodorante ou antitranspirante
MXPA03000430A (es) Nuevas arileteno-sulfonamidas.
DE60128009D1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
TR200103151T2 (tr) Karboksipeptidaz U inhibitörü ile trombin inhibitörünü içeren farmasötik bir formülasyon.
NO20006699D0 (no) Forbindelser med veksthormonfrigjörende egenskaper
SG165324A1 (en) Compositions and methods to counteract oral malodour
ZA200502464B (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome.
ATE390921T1 (de) Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1328268

Country of ref document: EP

EEIH Change in the person of patent owner